AIROS Medical appoints Darren Behuniak as COO

239
Behuniak is a founding partner of AIROS Medical and will expand his role as Chief Operating Officer.
Behuniak is a founding partner of AIROS Medical and will expand his role as Chief Operating Officer.

AIROS® Medical, Inc., a medical technology manufacturer and designer specializing in compression therapy devices that treat lymphedema and venous complications, yesterday announced it has named Darren M. Behuniak as its Chief Operating Officer. Behuniak is a co-founder of AIROS and has been serving as vice president of operations and marketing since the company’s founding in 2016.

Behuniak will oversee multiple business units including regulatory affairs, quality, supply chain management, and product development. He will also manage the company’s team of clinical advisors and will continue to work with the founding partners and executive team to align marketing and sales efforts.

AIROS Medical

“Darren has been a lynchpin at our organization and a key member of the management team since our inception seven years ago,” says Gerald Makoid, CEO and president of AIROS Medical. “He has helped drive AIROS’ growth from a start-up into a profitable small enterprise improving the lives of tens of thousands of people across the country. We will look to Darren to direct various business functions as we launch additional products, collaborate with strategic manufacturing partners, and expand sales outside of the United States this year and beyond.”

Prior to helping launch AIROS Medical, Behuniak was a corporate marketing and public relations executive in the health insurance, medical device, and information technology sectors. He has managed relationships with customers, partners, and suppliers across the United States, Europe, and Asia. He also founded a marketing communications firm specializing in lead generation, brand awareness, and social media.

Source

Also Read:

Regence BlueCross BlueShield of Utah names Mike Woodruff as Executive Medical Director

Ascend Capital Partners acquires majority stake in Seoul Medical Group

World Business Outlooks Awards 2024